Conditions placed on Ranbaxy acquisition
Sun Pharmaceuticals Industries can complete its $4 billion purchase of Ranbaxy Laboratories if it sells Ranbaxy’s interests in generic minocycline tablets to Torrent Pharmaceuticals Ltd., according to the Federal Trade Commission....To view the full article, register now.
Already a subscriber? Click here to view full article